{"id":"W1966679991","doi":"10.1016/j.clon.2013.08.011","title":"Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial","year":2013,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Durham","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Trastuzumab; Internal medicine; Oncology; Taxane; Breast cancer; Metastatic breast cancer; Adjuvant; Docetaxel; Adjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001821662,0.0007653087,0.001611871,0.0002520966,0.0002987481,0.0007888753,0.0005237088,0.0007434839,0.001072923],"category_scores_gemma":[0.00168205,0.0002105522,0.001418253,0.0003220282,0.0004948954,0.0007509249,0.0003213863,0.002176529,0.000227937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008814394,"about_ca_system_score_gemma":0.0007637445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001735865,"about_ca_topic_score_gemma":0.004022579,"domain_scores_codex":[0.9994362,0.0002522356,0.00002906539,0.00007271488,0.00006829792,0.0001414367],"domain_scores_gemma":[0.9994229,0.0001696748,0.0001254212,0.00005788177,0.00003405901,0.0001900286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6692218,0.01402804,0.0263198,0.0005958723,0.003050537,0.0004610918,0.0004677022,0.004103577,0.0112234,0.0002945193,0.006377514,0.2638562],"study_design_scores_gemma":[0.403911,0.3607894,0.2060428,0.0002078934,0.005743114,0.001085784,0.0003249918,0.004427409,0.005714614,0.0007115689,0.01096011,0.00008129958],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944848,0.003207284,0.0001157026,0.0004081602,0.0001120386,0.0001506458,0.0003188548,0.00001967586,0.001182736],"genre_scores_gemma":[0.9934343,0.002195822,0.0002601037,0.0007109256,0.0001681407,0.0001556948,0.001264001,0.00001514021,0.001795868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001821662,"threshold_uncertainty_score":0.009634018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1271280895894067,"score_gpt":0.4545716326262476,"score_spread":0.3274435430368408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}